[{"Assets_0_Q3_USD":309625000.0,"CommonStockSharesOutstanding_0_Q3_shares":627222076.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-72703000.0,"NetIncomeLoss_1_Q3_USD":5242000.0,"NetIncomeLoss_3_Q3_USD":-59341000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":621764201.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":573796275.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":582004954.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":573796275.0,"EarningsPerShareBasic_1_Q3_USD":0.01,"EarningsPerShareBasic_3_Q3_USD":-0.1,"EarningsPerShareDiluted_1_Q3_USD":0.01,"EarningsPerShareDiluted_3_Q3_USD":-0.1,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":40792000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":58026000.0,"Ticker":"ADAP","CIK":"1621227","name":"ADAPTIMMUNE THERAPEUTICS PLC","OfficialName":"Adaptimmune Therapeutics plc American Depositary Shares","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301181409.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]